From 10-Valent to 21-Valent Pneumococcal Conjugate Vaccines: Divergent Global Pathways and Future Directions for India
Indian Pediatrics · 2026-09 · 63 (9) · 684-690
DOI: 10.1007/s13312-026-00331-6 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Indian Pediatrics, online erschienen am 04.05.2026. Verfasst von Rajeev Zachariah Kompithra und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Child Health, Christian Medical College, Vellore, Tamil Nadu, India. Hauptthemen laut MEDLINE: Pneumococcal Vaccines, Pneumococcal Infections, Immunization Programs. Die Arbeit nennt 35 Literaturangaben.
Abstract (Originalsprache)
Pneumococcal conjugate vaccines (PCVs) have greatly reduced invasive pneumococcal disease worldwide, though outcomes vary with the serotype formulation and regional context. India's introduction of indigenous 10-valent PCV into its Universal Immunization Program (UIP) was a major milestone, differing from the earlier globally available PCV10 by including serotypes 19A and 6A-both of which have been linked to antimicrobial resistance (AMR) in countries such as Belgium and Brazil. This review synthesizes global vaccine experiences, explores serotype biology, cross-protection, and the emergence of non-vaccine types, and considers the spectrum of higher-valency options (PCV14, PCV20, and PCV21). India's pediatric PCV coverage has expanded rapidly, though unevenly, while adult uptake remains limited. While indigenous PCV10 introduction and scale-up, followed by indigenous PCV14 introduction seems a pragmatic policy for India's UIP today, sustained genomic and AMR surveillance, plus eventual transitions to broader PCVs, will be essential for long-term, adaptable immunization strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Child Health, Christian Medical College, Vellore, Tamil Nadu, India.
- Department of Clinical Microbiology, Christian Medical College, Vellore, Tamil Nadu, India.
- Department of Pediatric Nephrology, Christian Medical College, Vellore, Tamil Nadu, India.
- Department of Clinical Microbiology, Christian Medical College, Vellore, Tamil Nadu, India. vbalaji@cmcvellore.ac.in.
Zitieren
APA
Kompithra, R. Z., Varghese, R., Muruganantham, G., Mathew, G., & Veeraraghavan, B. (2026). From 10-Valent to 21-Valent Pneumococcal Conjugate Vaccines: Divergent Global Pathways and Future Directions for India. Indian Pediatrics, 63(9), 684-690. https://doi.org/10.1007/s13312-026-00331-6
Vancouver
Kompithra RZ, Varghese R, Muruganantham G, Mathew G, Veeraraghavan B. From 10-Valent to 21-Valent Pneumococcal Conjugate Vaccines: Divergent Global Pathways and Future Directions for India. Indian Pediatrics. 2026;63(9):684-690. doi:10.1007/s13312-026-00331-6
BibTeX
@article{Kompithra2026,
author = {Kompithra, Rajeev Zachariah and Varghese, Rosemol and Muruganantham, Gurumoorthy and Mathew, Georgie and Veeraraghavan, Balaji},
title = {From 10-Valent to 21-Valent Pneumococcal Conjugate Vaccines: Divergent Global Pathways and Future Directions for India},
journal = {Indian Pediatrics},
year = {2026},
volume = {63},
number = {9},
pages = {684--690},
doi = {10.1007/s13312-026-00331-6}
}
EUVIMED